1. Home
  2. KRYS vs IDA Comparison

KRYS vs IDA Comparison

Compare KRYS & IDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$241.84

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Logo IDACORP Inc.

IDA

IDACORP Inc.

HOLD

Current Price

$125.44

Market Cap

7.0B

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRYS
IDA
Founded
2015
1915
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Electric Utilities: Central
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
7.0B
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
KRYS
IDA
Price
$241.84
$125.44
Analyst Decision
Strong Buy
Buy
Analyst Count
9
7
Target Price
$214.22
$133.00
AVG Volume (30 Days)
286.6K
395.1K
Earning Date
11-03-2025
10-30-2025
Dividend Yield
N/A
2.80%
EPS Growth
275.72
7.17
EPS
6.66
5.84
Revenue
$373,164,000.00
$1,805,885,000.00
Revenue This Year
$36.14
$6.64
Revenue Next Year
$41.80
$7.70
P/E Ratio
$36.72
$21.55
Revenue Growth
54.51
N/A
52 Week Low
$122.80
$104.74
52 Week High
$248.60
$138.03

Technical Indicators

Market Signals
Indicator
KRYS
IDA
Relative Strength Index (RSI) 74.92 40.49
Support Level $213.83 $124.84
Resistance Level $248.60 $127.42
Average True Range (ATR) 7.44 2.12
MACD 1.29 -0.09
Stochastic Oscillator 78.92 19.83

Price Performance

Historical Comparison
KRYS
IDA

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About IDA IDACORP Inc.

Idacorp Inc is a holding company that, through its subsidiaries, acts as an electric utility engaged in the generation, transmission, distribution, sale, and purchase of electric energy and capacity. The companys only reportable segment is utility operations. The utility operations segment's primary source of revenue is the regulated operations of Idaho Power. The company serves commercial and industrial customers, which involved in food processing, electronics and general manufacturing, agriculture, health care, government, and education.

Share on Social Networks: